EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI 'S Nanotechnology Characterization Laboratory Service to the Research Community

Rachael M Crist iD, Yechezkel Barenholz, Ahuva Cern, Kate N Clark, Pieter R Cullis iD, Cheryl Dean, Neil Desai, Mauro Ferrari, Matthieu Germain, Carmen A Giacomantonio, Emma Grabarnik, Piotr Grodzinski iD und 18 weitere

WIREs Nanomedicine and Nanobiotechnology · 2025

DOI: 10.1002/wnan.70020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2025. Verfasst von Rachael M Crist und 29 weiteren Autor:innen. Beteiligte Einrichtung: Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the Na…. Hauptthemen laut MEDLINE: National Cancer Institute (U.S.), Neoplasms, Nanomedicine, Nanotechnology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Cancer Society - F.M. Kirby Foundation Inc. - Mission Boost Grant, NCI NIH HHS, Canadian Institutes of Health Research Doctoral Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Nanotechnology Characterization Laboratory (NCL) is a US federally funded resource providing characterization and expertise to the cancer nanomedicine research community. Founded as a formal partnership among the US National Cancer Institute (NCI), the US Food and Drug Administration (FDA), and the US National Institute of Standards and Technology (NIST), the NCL has spent two decades developing a one‐of‐a‐kind service with broad multidisciplinary expertise to meet the needs of a rapidly evolving drug development field. To mark the 20th anniversary of the lab's founding, the NCL hosted a symposium to highlight the achievements of the cancer nanomedicine field, showcase novel, next‐generation nanotechnology research, and discuss future priorities to enable continued growth in combating cancer and the complexities associated with treating a disease that continues to take millions of lives annually. The discussion topics from this event are summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

National Cancer Institute (U.S.)NeoplasmsNanomedicineNanotechnologyUnited StatesHumans

Stichwörter der Autor:innen

cancernanomedicinenanotechnology

Autor:innen und Institutionen

  • Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, Maryland, USA.
  • Laboratory of Membrane and Liposome Research, Department of Biochemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Aanastra, Los Angeles, California, USA.
  • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Rachael M Crist, Pieter R Cullis, Piotr Grodzinski, Ruvanthi N Kularatne, Nicole F Steinmetz, Yao Zhang, Jeffrey D Clogston

Förderung

  • American Cancer Society - F.M. Kirby Foundation Inc. - Mission Boost Grant
  • NCI NIH HHS
  • Canadian Institutes of Health Research Doctoral Award
  • Canadian Institutes for Health Research
  • DOD Breast Cancer Research Program
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Crist, R. M., Barenholz, Y., Cern, A., Clark, K. N., Cullis, P. R., Dean, C., Desai, N., Ferrari, M., Germain, M., Giacomantonio, C. A., Grabarnik, E., Grodzinski, P., Hod, A., Kennedy, B. E., Kularatne, R. N., Kwon, G. S., Loeb, E., Noftall, E. B., Pagliaro, L., …, & Dobrovolskaia, M. A. (2025). Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI 'S Nanotechnology Characterization Laboratory Service to the Research Community. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.70020

Vancouver

Crist RM, Barenholz Y, Cern A, Clark KN, Cullis PR, Dean C, et al. Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI 'S Nanotechnology Characterization Laboratory Service to the Research Community. WIREs Nanomedicine and Nanobiotechnology. 2025. doi:10.1002/wnan.70020

BibTeX
@article{Crist2025,
  author = {Crist, Rachael M and Barenholz, Yechezkel and Cern, Ahuva and Clark, Kate N and Cullis, Pieter R and Dean, Cheryl and Desai, Neil and Ferrari, Mauro and Germain, Matthieu and Giacomantonio, Carmen A and Grabarnik, Emma and Grodzinski, Piotr and Hod, Atara and Kennedy, Barry E and Kularatne, Ruvanthi N and Kwon, Glen S and Loeb, Emmanuel and Noftall, Erin B and Pagliaro, Len and Rasoulianboroujeni, Morteza and Roth, Alexander and Rowles, Darren and Singh, Kulbir and Steinmetz, Nicole F and Yehtina, Zhanna and Zhang, Yao and Zilbersheid, Daniel and Clogston, Jeffrey D and Stern, Stephan T and Dobrovolskaia, Marina A},
  title = {Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI 'S Nanotechnology Characterization Laboratory Service to the Research Community},
  journal = {WIREs Nanomedicine and Nanobiotechnology},
  year = {2025},
  doi = {10.1002/wnan.70020}
}
Kostenlos starten →